- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02832817
Accuracy and Precision of Different Devices for the Monitoring of Pulsed Oxygen Saturation (PULSEREA)
Hypoxemia is a frequent situation in clinical practice, particularly in intensive care units or perioperative. The mortality and morbidity increase for cardiovascular reason, due to hypoxia has been reported several times. It is therefore important to detect hypoxemia very early and with accuracy. The objective is to correct the causes quickly and thus avoid or minimize complications.
In addition to the risks associated with hypoxemia, the monitoring of Arterial Oxygen Saturation also avoids the adverse effects associated with hyperoxia. Indeed oxygen leads to the formation of free radicals, which in physiological condition are regulated by antioxidant mechanisms. However, in anesthesiology, it is common to find pathological situations (acute respiratory distress syndrome, shock, prolonged inflammatory state) where these regulatory mechanisms are overwhelmed. Oxygen administration to supra-physiological concentrations leads to a formation of excessive free radicals, aggravating the existing injury (including lung).
Oxygen therapy is a fully-fledged treatment requiring monitoring of its effectiveness and tolerance. Currently, the standard method for assessing oxygenation is the arterial blood gas analysis with the Arterial Oxygen Saturation. Its cost and the need for an arterial blood sample do not allow regular monitoring. Clinical evaluation of hypoxia is completely unreliable. there is a third method : monitoring devices that measure Arterial Pulsed Oxygen Saturation, called "pulse oximeters." Pulse oximeters have become an integral and mandatory part of the standard monitoring. It is through the measurement of Arterial Pulsed Oxygen Saturation, supposed to reflect Arterial Oxygen Saturation, that clinicians guide their therapeutic attitudes to optimize oxygenation and improve the prognosis of patients. So pulse oximetry is a method considered reliable and especially non-invasive. It is less expensive and does not require blood sampling. These qualities explain why these devices are easily used in anesthesia, intensive care and in emergency situations.
However, several studies have demonstrated the inaccuracy of Arterial Pulsed Oxygen Saturation in frequent situations resuscitation (shock, sepsis, dark skin type). Thus, it is necessary to objectify the benefits and limitations of pulse oximetry to optimize their use, especially in these situations of high risk, where a discrepancy between the values measured by the pulse oximetry and measurement of arterial blood saturation with oxygen gas can be detrimental.
It exists several pulse oximetry devices, whose accuracy seems unequal, which necessitates a comparative study.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Thomas REYDEL, Dr
- Phone Number: 0033 02413555225
- Email: Thomas.Reydel@chu-angers.fr
Study Contact Backup
- Name: Laurent BEYDON, Pr
- Phone Number: 0033 02413553951
- Email: labeydon@chu-angers.fr
Study Locations
-
-
-
Angers, France, 49933
- Recruiting
- Service de Réanimation Chirurgicale
-
Contact:
- Thomas REYDEL, Dr
- Email: Thomas.Reydel@chu-angers.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Hospitalization in intensive care
- Over 18 years
- Continuous monitoring of oxygen saturation
- Susceptible oo have arterial blood gases and carrying an arterial catheter
Exclusion Criteria:
- patient protected by the law
- no social security number
- carbon monoxide Intoxication
- High methemoglobinemia.
- Therapeutic limitation
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Crossover
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxygen saturation by pulse oximetry monitoring accuracy
Time Frame: at each arterial blood gas during ICU hospitalization (max 5 punctures from inclusion to ICU discharge - average of 1 week)
|
determine the accuracy of oxygen saturation by pulse oximetry monitoring devices (SpO2) compared to the reference method, arterial oxygen saturation (SaO2) by blood gas on Co-Oximeter
|
at each arterial blood gas during ICU hospitalization (max 5 punctures from inclusion to ICU discharge - average of 1 week)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants for whom there will be mismatch between SpO2 (oxygen saturation by pulse oximetry) and SaO2 (arterial oxygen saturation) measures with medical adverse events (vasopressors, hypoxemia, acidosis, alkalosis)
Time Frame: at each arterial blood gas during ICU hospitalization (max 5 punctures from inclusion to ICU discharge - average of 1 week)
|
highlight groups with risks of discrepancy between SpO2 and Sa02, and describe with the following criteria : presence of vasopressors, mechanical ventilation, blood lactate value, hypoxemia, acidosis / alkalosis, skin hypoperfusion signs, skin phototype, temperature.
|
at each arterial blood gas during ICU hospitalization (max 5 punctures from inclusion to ICU discharge - average of 1 week)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PULSEREA2016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arterial Pulsed Oxygen Saturation
-
Medtronic - MITGCompletedMonitoring Arterial Oxygen SaturationUnited States
-
Medline IndustriesClinimark, LLCCompletedHealthy | Arterial Oxygen SaturationUnited States
-
University of North Carolina, Chapel HillRecruitingOxygen SaturationUnited States
-
Peking University First HospitalAnhui Huami Information Technology Co., Ltd.Unknown
-
Seoul National University HospitalCompletedTissue Oxygen SaturationKorea, Republic of
-
University Hospital Schleswig-HolsteinCompletedTissue Oxygen SaturationGermany
-
Seers Technology Co., Ltd.CompletedOxygen SaturationKorea, Republic of
-
AZ Sint-Jan AVUnknown
-
Indiana UniversityCompletedOxygen SaturationUnited States
-
Ramathibodi HospitalNot yet recruitingCentral Venous Oxygen SaturationThailand
Clinical Trials on Pulse oximeter
-
William Beaumont HospitalsCompletedAsthma in Children | Respiratory Disease | Bronchiolitis Acute | Pneumonia in ChildrenUnited States
-
Nihon KohdenUniversity of California, San FranciscoCompleted
-
Nihon KohdenUniversity of California, San FranciscoActive, not recruiting
-
The Lifebox FoundationJohns Hopkins University; University College, London; Bill and Melinda Gates... and other collaboratorsCompletedPneumonia in Children | Measurement of Peripheral Oxygen SaturationUnited Kingdom, Bangladesh, Malawi
-
Belun Technology Company LimitedClinimark, LLCCompleted
-
Movano HealthUniversity of California, San FranciscoCompleted
-
Nihon KohdenUniversity of California, San FranciscoActive, not recruiting
-
Flashback TechnologiesDuke UniversityCompleted
-
Nonin Medical, IncClinimark, LLCCompleted